Industries > Pharma > Global Magnetic Resonance Imaging (MRI) Systems Market Forecast 2019-2029

Global Magnetic Resonance Imaging (MRI) Systems Market Forecast 2019-2029

High-Field MRI, Ultra-High Field MRI, Low-Field MRI

PUBLISHED: 08 January 2019
PAGES: 155
PRODUCT CODE: PHA0350
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
SKU: PHA0350 Categories: , Tags: ,

The global magnetic resonance imaging MRI systems market is expected to grow at a CAGR of 6.5% in the first half of the forecast period. In 2018, the high-field segment held 60% share of the global magnetic resonance imaging (MRI) systems.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 155-page report you will receive 108 charts – all unavailable elsewhere.

The 155-page report provides clear detailed insight into the global magnetic resonance imaging market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Magnetic Resonance Imaging (MRI) Systems Market forecast from 2019-2029

• Global Magnetic Resonance Imaging (MRI) Systems market forecast by field strength:
• High-Field MRI
• Ultra-High Field MRI
• Low-Field MRI

• Global Magnetic Resonance Imaging (MRI) Systems by National Market forecast 2019-2029, covering:
• US
• Japan
• Germany
• France
• The UK
• Italy
• Spain
• China
• India
• Brazil
• Russia
• Rest of the World (RoW)

Global Magnetic Resonance Imaging (MRI) Systems Market Forecast 2019-2029

Each national market forecast is further segmented by field strength.

• Assessment of selected leading companies that are the main players in the magnetic resonance imaging (MRI) systems market:
• Aurora Healthcare US Corp
• Bruker Corporation
• Canon Medical Systems
• Esaote SpA
• GE Healthcare
• Hitachi, Ltd.
• Neusoft Medical Systems Co., Ltd.
• Philips Healthcare
• Shenzhen Anke High-tech Co., Ltd.
• Siemens Healthineers

• This report provides a SWOT and STEP analysis of the global magnetic resonance imaging (MRI) systems market.

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Magnetic Resonance Imaging (MRI) Systems Market. You find data, trends and predictions.

Buy our report today Global Magnetic Resonance Imaging Systems Market Forecast 2019-2029: High-Field MRI, Ultra-High Field MRI, Low-Field MRI

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Magnetic Resonance Imaging (MRI) Systems Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Magnetic Resonance Imaging (MRI) Systems Market Forecast 2019-2029


Latest Pharma news

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2021-2031

Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.

12 July 2021

READ

Categories